Histone-lysine N-methyltransferase EZH2 (291-299)

Histone-lysine N-methyltransferase EZH2 (291-299) is a synthetic peptide fragment derived from the catalytic subunit of the Polycomb Repressive Complex 2 (PRC2), a key epigenetic regulator involved in chromatin remodeling and gene silencing. This peptide encompasses residues 291 to 299 of the EZH2 protein, a region implicated in substrate recognition and enzymatic activity modulation. As a biochemically relevant tool, it is utilized in studies of histone methylation, protein-protein interactions, and the intricate mechanisms governing epigenetic regulation. Its defined sequence and structural attributes make it a valuable reagent for dissecting the functional domains of EZH2 and exploring the broader landscape of chromatin biology.

Epigenetic research: As a model substrate or competitive inhibitor, the EZH2 (291-299) peptide is widely employed in investigations of histone methylation dynamics. Researchers leverage its sequence to probe the specificity and catalytic mechanisms of the PRC2 complex, particularly in relation to H3K27 methylation. By incorporating this peptide into in vitro assays, it becomes possible to delineate the contribution of the 291-299 region to substrate binding and enzymatic efficiency, thereby advancing the understanding of how lysine methylation patterns are established and maintained within chromatin.

Protein-protein interaction studies: The peptide serves as a molecular probe for mapping interaction sites within the PRC2 complex and its associated cofactors. By introducing the 291-299 fragment in binding assays or pull-down experiments, scientists can identify and characterize regions of EZH2 that mediate contacts with other core complex members or regulatory proteins. Such studies are instrumental in elucidating the assembly, stability, and functional modulation of PRC2 in various biological contexts.

Peptide inhibitor development: Given its origin from a catalytically significant domain, the EZH2 (291-299) fragment is often used as a template or reference in the design of peptide-based inhibitors targeting histone methyltransferase activity. Structure-activity relationship analyses utilizing this sequence can inform the rational development of analogs or mimetics aimed at modulating PRC2 function. These efforts are crucial for advancing chemical biology research and for the identification of novel molecular tools to interrogate epigenetic processes.

Enzyme assay calibration: The defined biochemical properties of the 291-299 peptide make it suitable as a reference substrate or control in quantitative methyltransferase assays. Its use enables the standardization of experimental conditions, validation of assay sensitivity, and benchmarking of enzymatic activity across different experimental platforms. This application supports the generation of reproducible and comparable data in high-throughput screening or mechanistic enzymology studies.

Structural biology: In structural and biophysical investigations, the EZH2 (291-299) peptide facilitates the analysis of peptide-enzyme complexes by techniques such as X-ray crystallography or NMR spectroscopy. Incorporation of this fragment into co-crystallization or binding experiments allows researchers to resolve interaction interfaces and conformational changes associated with substrate engagement. Insights derived from such studies contribute to a detailed molecular understanding of PRC2 function and inform the broader field of chromatin architecture and regulation.

1. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I